Document Detail


The efficacy of psoralen photochemotherapy in the treatment of aquagenic pruritus.
MedLine Citation:
PMID:  7654576     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Psoralen photochemotherapy (PUVA) was effective in the treatment of five patients with aquagenic pruritus, associated in one with polycythaemia rubra vera and in another with the myelodysplastic syndrome. Relapse occurred within 2-24 weeks when treatment was discontinued. Maintenance therapy or a further course of PUVA was necessary to maintain remission. This requirement may limit the value of the therapy.
Authors:
H D Menagé; P G Norris; J L Hawk; M W Graves
Related Documents :
8186116 - Successful outcome of cryosurgery in patients with granuloma annulare.
14616356 - Treatment of lentigo maligna with topical imiquimod.
11147086 - An observation study evaluating the efficacy of tazarotene plus corticosteroid in treat...
23086366 - Graft rejection and graft failure after penetrating keratoplasty or posterior lamellar ...
8345596 - The valved s-shaped rectosigmoid pouch for continent urinary diversion.
11054216 - Practicability and quality of outpatient management of acute deep venous thrombosis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The British journal of dermatology     Volume:  129     ISSN:  0007-0963     ISO Abbreviation:  Br. J. Dermatol.     Publication Date:  1993 Aug 
Date Detail:
Created Date:  1995-10-02     Completed Date:  1995-10-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0004041     Medline TA:  Br J Dermatol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  163-5     Citation Subset:  IM    
Affiliation:
St John's Institute of Dermatology, St Thomas' Hospital, London, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Female
Follow-Up Studies
Humans
Male
Middle Aged
Myelodysplastic Syndromes / complications
PUVA Therapy*
Polycythemia / complications
Pruritus / drug therapy*,  etiology,  prevention & control
Recurrence
Remission Induction
Water / adverse effects*
Chemical
Reg. No./Substance:
7732-18-5/Water

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Skin pigmentation due to minocycline treatment of facial dermatoses.
Next Document:  Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approa...